Moira Barbieri
Moira Barbieri has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Tamara Stampalija
Department of Medical, Surgical and Health Sciences University of Trieste Trieste Italy
6 shared publications - Enrico Ferrazzi
Unit of Obstetrics, Department of Woman, Child and Neonate Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
4 shared publications - Ilaria Fantasia
Obstetrics & Gynecology Unit, Hospital San Salvatore, 67100 L’Aquila, Italy
3 shared publications - Andrea Dall'ASta
Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy
2 shared publications C. Ottaviani
Unit of Fetal Medicine and Prenatal Diagnosis Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy
2 shared publicationsF. Lisi
Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology University of Florence Florence Italy
2 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by S. Karger AG in Maternal and Children's Health
- p. 1-16
Beyond aneuploidies: exploring the glycometabolic link to pregnancy-associated Plasma Protein A in pregestational diabetes
Pregnancy-associated plasma protein-A (PAPP-A) is a glycoprotein produced by the syncytiotrophoblast and the decidua during pregnancy, and other tissues, including vascular smooth muscle cells and fibroblasts. Type 2 diabetes is associated with chronically low PAPP-A levels. These low values contribute to vascular dysfunction and impaired metabolic health This retrospective study investigated whether PAPP-A levels are correlated with glycated hemoglobin (HbA1c), a marker of glycometabolic control, in pregnant women with type 1 and type 2 pre-GD who underwent first-trimester combined screening. Among the 96 women analyzed, a significant inverse correlation was observed in type 1 pre-GD between PAPP-A and both pregestational and first trimester HbA1c values (R = –0.69 and –0.49; p < 0.01). In type 2 pre-GD, multivariate analysis revealed that for each unit increase in HbA1c, PAPP-A decreased by 0.03 units in Caucasian women, but increased by 2.7 units in South American women. These findings suggest that glycometabolic compensation influences PAPP-A levels and should be considered when calculating aneuploidy risk. Rather than categorizing pre-GD history as a binary variable, incorporating HbA1c as a continuous parameter may improve the accuracy of risk assessment in first trimester screening for aneuploidies.
- 4 March 2026
- Published by S. Karger AG in Maternal and Children's Health
- p. 1-16
Open AccessBeyond aneuploidies: exploring the glycometabolic link to pregnancy-associated Plasma Protein A in pregestational diabetes
Pregnancy-associated plasma protein-A (PAPP-A) is a glycoprotein produced by the syncytiotrophoblast and the decidua during pregnancy, and other tissues, including vascular smooth muscle cells and fibroblasts. Type 2 diabetes is associated with chronically low PAPP-A levels. These low values contribute to vascular dysfunction and impaired metabolic health This retrospective study investigated whether PAPP-A levels are correlated with glycated hemoglobin (HbA1c), a marker of glycometabolic control, in pregnant women with type 1 and type 2 pre-GD who underwent first-trimester combined screening. Among the 96 women analyzed, a significant inverse correlation was observed in type 1 pre-GD between PAPP-A and both pregestational and first trimester HbA1c values (R = –0.69 and –0.49; p < 0.01). In type 2 pre-GD, multivariate analysis revealed that for each unit increase in HbA1c, PAPP-A decreased by 0.03 units in Caucasian women, but increased by 2.7 units in South American women. These findings suggest that glycometabolic compensation influences PAPP-A levels and should be considered when calculating aneuploidy risk. Rather than categorizing pre-GD history as a binary variable, incorporating HbA1c as a continuous parameter may improve the accuracy of risk assessment in first trimester screening for aneuploidies.
- Open Access
- 30 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2654
Reply to Rubin, J.M.; Kripfgans, O.D. Comment on “Barbieri et al. Umbilical Vein Blood Flow in Uncomplicated Pregnancies: Systematic Review of Available Reference Charts and Comparison with a New Cohort. J. Clin. Med. 2023, 12, 3132”
We thank the authors for the interest in our paper
- 30 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2654
Open AccessReply to Rubin, J.M.; Kripfgans, O.D. Comment on “Barbieri et al. Umbilical Vein Blood Flow in Uncomplicated Pregnancies: Systematic Review of Available Reference Charts and Comparison with a New Cohort. J. Clin. Med. 2023, 12, 3132”
We thank the authors for the interest in our paper
- Open Access
- 28 October 2023
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 34 (3) , 771-782
A longitudinal study on the effect of obesity upon circulating renin-angiotensin system in normal pregnancy
- 28 October 2023
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 34 (3) , 771-782
Open AccessA longitudinal study on the effect of obesity upon circulating renin-angiotensin system in normal pregnancy
- Open Access
- 26 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (9) , 3132
Umbilical Vein Blood Flow in Uncomplicated Pregnancies: Systematic Review of Available Reference Charts and Comparison with a New Cohort
The objectives of the study were (1) to perform a systematic review of the available umbilical vein blood flow volume (UV-Q) reference ranges in uncomplicated pregnancies; and (2) to compare the findings of the systematic review with UV-Q values obtained from a local cohort. Available literature in the English language on this topic was identified following the PRISMA guidelines. Selected original articles were further grouped based on the UV sampling sites and the formulae used to compute UV-Q. The 50th percentiles, the means, or the best-fitting curves were derived from the formulae or the reported tables presented by authors. A prospective observational study of uncomplicated singleton pregnancies from 20+0 to 40+6 weeks of gestation was conducted to compare UV-Q with the results of this systematic review. Fifteen sets of data (fourteen sets belonging to manuscripts identified by the research strategy and one obtained from our cohort) were compared. Overall, there was a substantial heterogeneity among the reported UV-Q central values, although when using the same sampling methodology and formulae, the values overlap. Our data suggest that when adhering to the same methodology, the UV-Q assessment is accurate and reproducible, thus encouraging further investigation on the possible clinical applications of this measurement in clinical practice.
- 26 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (9) , 3132
Open AccessUmbilical Vein Blood Flow in Uncomplicated Pregnancies: Systematic Review of Available Reference Charts and Comparison with a New Cohort
The objectives of the study were (1) to perform a systematic review of the available umbilical vein blood flow volume (UV-Q) reference ranges in uncomplicated pregnancies; and (2) to compare the findings of the systematic review with UV-Q values obtained from a local cohort. Available literature in the English language on this topic was identified following the PRISMA guidelines. Selected original articles were further grouped based on the UV sampling sites and the formulae used to compute UV-Q. The 50th percentiles, the means, or the best-fitting curves were derived from the formulae or the reported tables presented by authors. A prospective observational study of uncomplicated singleton pregnancies from 20+0 to 40+6 weeks of gestation was conducted to compare UV-Q with the results of this systematic review. Fifteen sets of data (fourteen sets belonging to manuscripts identified by the research strategy and one obtained from our cohort) were compared. Overall, there was a substantial heterogeneity among the reported UV-Q central values, although when using the same sampling methodology and formulae, the values overlap. Our data suggest that when adhering to the same methodology, the UV-Q assessment is accurate and reproducible, thus encouraging further investigation on the possible clinical applications of this measurement in clinical practice.
- Open Access
- 13 February 2023
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 51 (2) , 318-325
Umbilical vein blood flow: State‐of‐the‐art
Placental blood supply to the fetus can be measured by evaluating the umbilical vein blood flow. Despite its potential application in healthcare, the umbilical vein blood flow volume is still used only in research setting. One of the reasons is a concern regarding its reproducibility, partly due to technology issues. Nowadays, technology improvements make this evaluation accurate and reproducible. The aim of this review is to refresh basic elements of the physiology of umbilical vein blood flow and its analysis. Its evaluation in normal and abnormal fetal growth is also discussed.
- 13 February 2023
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 51 (2) , 318-325
Open AccessUmbilical vein blood flow: State‐of‐the‐art
Placental blood supply to the fetus can be measured by evaluating the umbilical vein blood flow. Despite its potential application in healthcare, the umbilical vein blood flow volume is still used only in research setting. One of the reasons is a concern regarding its reproducibility, partly due to technology issues. Nowadays, technology improvements make this evaluation accurate and reproducible. The aim of this review is to refresh basic elements of the physiology of umbilical vein blood flow and its analysis. Its evaluation in normal and abnormal fetal growth is also discussed.
- Open Access
- 1 November 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 60 (5) , 632-639
Incidence, clinical features and perinatal outcome in anomalous fetuses with late‐onset growth restriction: cohort study
Objective: To describe the incidence, clinical features and perinatal outcome of late‐onset fetal growth restriction (FGR) associated with genetic syndrome or aneuploidy, structural malformation or congenital infection.Methods: This was a retrospective multicenter cohort study of patients who attended one of four tertiary maternity hospitals in Italy. We included consecutive singleton pregnancies between 32 + 0 and 36 + 6 weeks' gestation with either fetal abdominal circumference (AC) or estimated fetal weight < 10th percentile for gestational age or a reduction in AC of > 50 percentiles from the measurement at an ultrasound scan performed between 18 and 32 weeks. The study group consisted of pregnancies with late‐onset FGR and a genetic syndrome or aneuploidy, structural malformation or congenital infection (anomalous late‐onset FGR). The presence of congenital anomalies was ascertained postnatally in neonates with abnormal findings on antenatal investigation or detected after birth. The control group consisted of pregnancies with structurally and genetically normal fetuses with late‐onset FGR. Composite adverse perinatal outcome was defined as the presence of at least one of stillbirth, 5‐min Apgar score < 7, admission to the neonatal intensive care unit (NICU), need for respiratory support at birth, neonatal jaundice and neonatal hypoglycemia. The primary aims of the study were to assess the incidence and clinical features of anomalous late‐onset FGR, and to compare the perinatal outcome of such cases with that of fetuses with non‐anomalous late‐onset FGR.Results: Overall, 1246 pregnancies complicated by late‐onset FGR were included in the study, of which 120 (9.6%) were allocated to the anomalous late‐onset FGR group. Of these, 11 (9.2%) had a genetic syndrome or aneuploidy, 105 (87.5%) had an isolated structural malformation, and four (3.3%) had a congenital infection. The most frequent structural defects associated with late‐onset anomalous FGR were genitourinary malformations (28/105 (26.7%)) and limb malformation (21/105 (20.0%)). Compared with the non‐anomalous late‐onset FGR group, fetuses with anomalous late‐onset FGR had an increased incidence of composite adverse perinatal outcome (35.9% vs 58.3%; P < 0.01). Newborns with anomalous, compared to those with non‐anomalous, late‐onset FGR showed a higher frequency of need for respiratory support at birth (25.8% vs 9.0%; P < 0.01), intubation (10.0% vs 1.1%; P < 0.01), NICU admission (43.3% vs 22.6%; P < 0.01) and longer hospital stay (median, 24 days (range, 4–250 days) vs 11 days (range, 2–59 days); P < 0.01).Conclusions: Most pregnancies complicated by anomalous late‐onset FGR have structural malformations rather than genetic abnormality or infection. Fetuses with anomalous late‐onset FGR have an increased incidence of complications at birth and NICU admission and a longer hospital stay compared with fetuses with isolated late‐onset FGR. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- 1 November 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 60 (5) , 632-639
Open AccessIncidence, clinical features and perinatal outcome in anomalous fetuses with late‐onset growth restriction: cohort study
Objective: To describe the incidence, clinical features and perinatal outcome of late‐onset fetal growth restriction (FGR) associated with genetic syndrome or aneuploidy, structural malformation or congenital infection.Methods: This was a retrospective multicenter cohort study of patients who attended one of four tertiary maternity hospitals in Italy. We included consecutive singleton pregnancies between 32 + 0 and 36 + 6 weeks' gestation with either fetal abdominal circumference (AC) or estimated fetal weight < 10th percentile for gestational age or a reduction in AC of > 50 percentiles from the measurement at an ultrasound scan performed between 18 and 32 weeks. The study group consisted of pregnancies with late‐onset FGR and a genetic syndrome or aneuploidy, structural malformation or congenital infection (anomalous late‐onset FGR). The presence of congenital anomalies was ascertained postnatally in neonates with abnormal findings on antenatal investigation or detected after birth. The control group consisted of pregnancies with structurally and genetically normal fetuses with late‐onset FGR. Composite adverse perinatal outcome was defined as the presence of at least one of stillbirth, 5‐min Apgar score < 7, admission to the neonatal intensive care unit (NICU), need for respiratory support at birth, neonatal jaundice and neonatal hypoglycemia. The primary aims of the study were to assess the incidence and clinical features of anomalous late‐onset FGR, and to compare the perinatal outcome of such cases with that of fetuses with non‐anomalous late‐onset FGR.Results: Overall, 1246 pregnancies complicated by late‐onset FGR were included in the study, of which 120 (9.6%) were allocated to the anomalous late‐onset FGR group. Of these, 11 (9.2%) had a genetic syndrome or aneuploidy, 105 (87.5%) had an isolated structural malformation, and four (3.3%) had a congenital infection. The most frequent structural defects associated with late‐onset anomalous FGR were genitourinary malformations (28/105 (26.7%)) and limb malformation (21/105 (20.0%)). Compared with the non‐anomalous late‐onset FGR group, fetuses with anomalous late‐onset FGR had an increased incidence of composite adverse perinatal outcome (35.9% vs 58.3%; P < 0.01). Newborns with anomalous, compared to those with non‐anomalous, late‐onset FGR showed a higher frequency of need for respiratory support at birth (25.8% vs 9.0%; P < 0.01), intubation (10.0% vs 1.1%; P < 0.01), NICU admission (43.3% vs 22.6%; P < 0.01) and longer hospital stay (median, 24 days (range, 4–250 days) vs 11 days (range, 2–59 days); P < 0.01).Conclusions: Most pregnancies complicated by anomalous late‐onset FGR have structural malformations rather than genetic abnormality or infection. Fetuses with anomalous late‐onset FGR have an increased incidence of complications at birth and NICU admission and a longer hospital stay compared with fetuses with isolated late‐onset FGR. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- Open Access
- 3 March 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 59 (3) , 342-349
Ultrasound prediction of adverse perinatal outcome at diagnosis of late‐onset fetal growth restriction
Objective: To evaluate the relationship between Doppler and biometric ultrasound parameters measured at diagnosis and perinatal adverse outcome in a cohort of late‐onset growth‐restricted (FGR) fetuses.Methods: This was a multicenter retrospective study of data obtained between 2014 and 2019 including non‐anomalous singleton pregnancies complicated by late‐onset FGR (≥ 32 weeks), which was defined either as abdominal circumference (AC) or estimated fetal weight (EFW) < 10th percentile for gestational age or as reduction of the longitudinal growth of AC by over 50 percentiles compared to ultrasound scan performed between 18 and 32 weeks of gestation. We evaluated the association between sonographic findings at diagnosis of FGR and composite adverse perinatal outcome (CAPO), defined as stillbirth or at least two of the following: obstetric intervention due to intrapartum fetal distress, neonatal acidemia, birth weight < 3rd percentile and transfer to the neonatal intensive care unit (NICU).Results: Overall, 468 cases with complete biometric and umbilical, fetal middle cerebral and uterine artery (UtA) Doppler data were included, of which 53 (11.3%) had CAPO. On logistic regression analysis, only EFW percentile was associated independently with CAPO (P = 0.01) and NICU admission (P < 0.01), while the mean UtA pulsatility index (PI) multiples of the median (MoM) > 95th percentile at diagnosis was associated independently with obstetric intervention due to intrapartum fetal distress (P = 0.01). The model including baseline pregnancy characteristics and the EFW percentile was associated with an area under the receiver‐operating‐characteristics curve of 0.889 (95% CI, 0.813–0.966) for CAPO (P < 0.001). A cut‐off value for EFW corresponding to the 3.95th percentile was found to discriminate between cases with and those without CAPO, yielding a sensitivity of 58.5% (95% CI, 44.1–71.9%), specificity of 69.6% (95% CI, 65.0–74.0%), positive predictive value of 19.8% (95% CI, 13.8–26.8%) and negative predictive value of 92.9% (95% CI, 89.5–95.5%).Conclusions: Retrospective data from a large cohort of late‐onset FGR fetuses showed that EFW at diagnosis is the only sonographic parameter associated independently with the occurrence of CAPO, while mean UtA‐PI MoM > 95th percentile at diagnosis is associated independently with intrapartum distress leading to obstetric intervention. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- 3 March 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 59 (3) , 342-349
Open AccessUltrasound prediction of adverse perinatal outcome at diagnosis of late‐onset fetal growth restriction
Objective: To evaluate the relationship between Doppler and biometric ultrasound parameters measured at diagnosis and perinatal adverse outcome in a cohort of late‐onset growth‐restricted (FGR) fetuses.Methods: This was a multicenter retrospective study of data obtained between 2014 and 2019 including non‐anomalous singleton pregnancies complicated by late‐onset FGR (≥ 32 weeks), which was defined either as abdominal circumference (AC) or estimated fetal weight (EFW) < 10th percentile for gestational age or as reduction of the longitudinal growth of AC by over 50 percentiles compared to ultrasound scan performed between 18 and 32 weeks of gestation. We evaluated the association between sonographic findings at diagnosis of FGR and composite adverse perinatal outcome (CAPO), defined as stillbirth or at least two of the following: obstetric intervention due to intrapartum fetal distress, neonatal acidemia, birth weight < 3rd percentile and transfer to the neonatal intensive care unit (NICU).Results: Overall, 468 cases with complete biometric and umbilical, fetal middle cerebral and uterine artery (UtA) Doppler data were included, of which 53 (11.3%) had CAPO. On logistic regression analysis, only EFW percentile was associated independently with CAPO (P = 0.01) and NICU admission (P < 0.01), while the mean UtA pulsatility index (PI) multiples of the median (MoM) > 95th percentile at diagnosis was associated independently with obstetric intervention due to intrapartum fetal distress (P = 0.01). The model including baseline pregnancy characteristics and the EFW percentile was associated with an area under the receiver‐operating‐characteristics curve of 0.889 (95% CI, 0.813–0.966) for CAPO (P < 0.001). A cut‐off value for EFW corresponding to the 3.95th percentile was found to discriminate between cases with and those without CAPO, yielding a sensitivity of 58.5% (95% CI, 44.1–71.9%), specificity of 69.6% (95% CI, 65.0–74.0%), positive predictive value of 19.8% (95% CI, 13.8–26.8%) and negative predictive value of 92.9% (95% CI, 89.5–95.5%).Conclusions: Retrospective data from a large cohort of late‐onset FGR fetuses showed that EFW at diagnosis is the only sonographic parameter associated independently with the occurrence of CAPO, while mean UtA‐PI MoM > 95th percentile at diagnosis is associated independently with intrapartum distress leading to obstetric intervention. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- 1 September 2021
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 264, 60-64
Prenatal diagnosis of isolated clubfoot: Diagnostic accuracy and long-term postnatal outcomes
- 1 September 2021
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 264, 60-64
Prenatal diagnosis of isolated clubfoot: Diagnostic accuracy and long-term postnatal outcomes
- 5 July 2021
- Published by Taylor & Francis in Future Microbiology
- Vol. 16 (11) , 801-810
Evidence of Bacterial DNA Presence in Chorionic Villi and Amniotic Fluid in the First and Second Trimester of Pregnancy
The sterile-womb dogma in uncomplicated pregnancy has been lively debated. Data regarding the in utero microbiome environment are based mainly on studies performed at the time of delivery. Aim: To ...
- 5 July 2021
- Published by Taylor & Francis in Future Microbiology
- Vol. 16 (11) , 801-810
Evidence of Bacterial DNA Presence in Chorionic Villi and Amniotic Fluid in the First and Second Trimester of Pregnancy
The sterile-womb dogma in uncomplicated pregnancy has been lively debated. Data regarding the in utero microbiome environment are based mainly on studies performed at the time of delivery. Aim: To ...
- Open Access
Relationship between Deceleration Morphology and Phase Rectified Signal Averaging-based Parameters during Labor
During labor, uterine contractions trigger the response of the autonomic nervous system (ANS) of the fetus, producing sawtooth-like decelerations in the fetal heart rate (FHR) series. Under chronic hypoxia, ANS is known to regulate FHR differently with respect to healthy fetuses. In this study, we hypothesized that such different ANS regulation might also lead to a change in the FHR deceleration morphology. The hypothesis was tested in an animal model comprising 7 normoxic and 5 chronically hypoxic fetuses that underwent a protocol of umbilical cord occlusions (UCOs). Deceleration morphologies in the fetal inter-beat time interval (FRR) series were modeled using a trapezoid with four parameters, i.e., baseline b , deceleration depth a , UCO response time τ u and recovery time τ r . Comparing normoxic and hypoxic sheep, we found a clear difference for τ u (24.8 ± 9.4 vs 39.8 ± 9.7 s; p < 0.05), a (268.1 ± 109.5 vs 373.0 ± 46.0 ms; p < 0.1) and Δ τ = τ u − τ r (13.2 ± 6.9 vs 23.9 ± 7.5 s; p < 0.05). Therefore, the animal model supported the hypothesis that hypoxic fetuses have a longer response time τ u and larger asymmetry Δ τ as a response to UCOs. Assessing these morphological parameters during labor is challenging due to non-stationarity, phase desynchronization and noise. For this reason, in the second part of the study, we quantified whether acceleration capacity (AC), deceleration capacity (DC), and deceleration reserve (DR), computed through Phase-Rectified Signal Averaging (PRSA, known to be robust to noise), were correlated with the morphological parameters. DR and DC correlated with Δ τ and τ u for a wide range of the PRSA parameter T (max Pearson’s correlation ρ = 0.9, p < 0.05, and ρ = 0.6, p < 0.1, respectively). In conclusion, deceleration morphologies have been found to differ between normoxic and hypoxic sheep fetuses during UCOs. The same difference can be assessed through PRSA based parameters, further motivating future investigations on the translational potential of this methodology on human data.
Open AccessRelationship between Deceleration Morphology and Phase Rectified Signal Averaging-based Parameters during Labor
During labor, uterine contractions trigger the response of the autonomic nervous system (ANS) of the fetus, producing sawtooth-like decelerations in the fetal heart rate (FHR) series. Under chronic hypoxia, ANS is known to regulate FHR differently with respect to healthy fetuses. In this study, we hypothesized that such different ANS regulation might also lead to a change in the FHR deceleration morphology. The hypothesis was tested in an animal model comprising 7 normoxic and 5 chronically hypoxic fetuses that underwent a protocol of umbilical cord occlusions (UCOs). Deceleration morphologies in the fetal inter-beat time interval (FRR) series were modeled using a trapezoid with four parameters, i.e., baseline b , deceleration depth a , UCO response time τ u and recovery time τ r . Comparing normoxic and hypoxic sheep, we found a clear difference for τ u (24.8 ± 9.4 vs 39.8 ± 9.7 s; p < 0.05), a (268.1 ± 109.5 vs 373.0 ± 46.0 ms; p < 0.1) and Δ τ = τ u − τ r (13.2 ± 6.9 vs 23.9 ± 7.5 s; p < 0.05). Therefore, the animal model supported the hypothesis that hypoxic fetuses have a longer response time τ u and larger asymmetry Δ τ as a response to UCOs. Assessing these morphological parameters during labor is challenging due to non-stationarity, phase desynchronization and noise. For this reason, in the second part of the study, we quantified whether acceleration capacity (AC), deceleration capacity (DC), and deceleration reserve (DR), computed through Phase-Rectified Signal Averaging (PRSA, known to be robust to noise), were correlated with the morphological parameters. DR and DC correlated with Δ τ and τ u for a wide range of the PRSA parameter T (max Pearson’s correlation ρ = 0.9, p < 0.05, and ρ = 0.6, p < 0.1, respectively). In conclusion, deceleration morphologies have been found to differ between normoxic and hypoxic sheep fetuses during UCOs. The same difference can be assessed through PRSA based parameters, further motivating future investigations on the translational potential of this methodology on human data.